Study on the best concentration of miRNA-22 agomir in the treatment of temporal lobe epilepsy by single injection of lateral ventricle
10.3760/cma.j.issn.1008-1372.2019.02.010
- VernacularTitle:经侧脑室单次注射miRNA-22agomir治疗颞叶癫痫起效最佳浓度的探讨
- Author:
Qiubo LI
1
;
Xingrao WU
;
Qingxia KONG
;
Fenghai NIU
;
Guangfei SUN
;
Cuiping ZHU
;
Xu CHU
Author Information
1. 济宁医学院附属医院儿科 272000
- Keywords:
Epilepsy;
temporal lobe;
MicroRNAs;
Lateral ventricles;
Injections;
intraventricular;
Receptors,purinergic P2X7;
Rats
- From:
Journal of Chinese Physician
2019;21(2):197-200,206
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the optimal initial concentration of microRNA22 agomir in epilepsy model induced by lithium chloride-pilocarpine after single injection of lateral ventricle.Methods 36 rats with acute temporal lobe epilepsy were randomly divided into 6 groups:the control group and the other five groups were the experimental group.All epilepsy rats were selected for right lateral ventricle injection.The control group was given negative control reagent,while the experimental group were given 0.1 mmol/L,2.5 mmol/L,5 mmol/L,10 mmol/L,20 mmol/L different concentrations of miRNA22agomir reagent.6 rats in each group were randomly selected for acute phase experiment after 3 days of administration.The expression of P2X7 in hippocampus of epilepsy rats was determined by Western blot and quantitative real-time polymerase chain reaction (qRT-PCR).Results Compared with control group,the protein and mRNA expression of P2X7 reduced in all of the model group.The protein and mRNA expression level of P2X7 protein in hippocampus of rats injected with 2.5 mmol/L,5 mmol/L and 10 mmol/L in each experimental group were significantly lower than that in the other two groups (P ＜ 0.05).Moreover,the protein and mRNA expression level of P2X7 were the lowest at 2.5 mmol/L injection and 10 mmol/L,and there was no significant difference between the two groups (P ＞ 0.05).Conclusions The optimal onset concentration for unilateral lateral ventricle injection miRNA22 agomir treatment of temporal lobe epilepsy is 2.5 mmol/L.
